tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PASG Stock Latest News

Passage Bio Advances Gene Therapy for Neurodegenerative Diseases
Company AnnouncementsPassage Bio Advances Gene Therapy for Neurodegenerative Diseases
2M ago
PASG
Strategic Restructuring and Promising Data Catalysts Drive Buy Rating for Passage Bio
PremiumRatings
Strategic Restructuring and Promising Data Catalysts Drive Buy Rating for Passage Bio
2M ago
PASG
Passage Bio price target lowered to $6 from $7 at Chardan
PremiumThe Fly
Passage Bio price target lowered to $6 from $7 at Chardan
2M ago
PASG
Passage Bio: Promising Clinical Progress and Strong Financial Health Support Buy Rating
PremiumRatings
Passage Bio: Promising Clinical Progress and Strong Financial Health Support Buy Rating
2M ago
PASG
Passage Bio Reports 2024 Financial Results and Program Advances
PremiumCompany Announcements
Passage Bio Reports 2024 Financial Results and Program Advances
2M ago
8K
PASG
Passage Bio reports FY24 EPS ($1.07) vs ($1.86) last year
PremiumThe FlyPassage Bio reports FY24 EPS ($1.07) vs ($1.86) last year
2M ago
PASG
Passage Bio announces data from upliFT-D study in FTD-GRN, provides update
Premium
The Fly
Passage Bio announces data from upliFT-D study in FTD-GRN, provides update
3M ago
PASG
Passage Bio Restructures and Extends Cash Runway
Premium
Company Announcements
Passage Bio Restructures and Extends Cash Runway
3M ago
8K
PASG
Passage Bio assumed with an Outperform at Wedbush
PremiumThe Fly
Passage Bio assumed with an Outperform at Wedbush
5M ago
PASG
Passage Bio Shows Progress in Gene Therapy Trials
PremiumCompany Announcements
Passage Bio Shows Progress in Gene Therapy Trials
5M ago
PASG
Passage Bio Achieves Milestones in Gene Therapy Trials
PremiumCompany Announcements
Passage Bio Achieves Milestones in Gene Therapy Trials
5M ago
8K
PASG
Passage Bio reports Q3 EPS (31c), consensus (23c)
PremiumThe Fly
Passage Bio reports Q3 EPS (31c), consensus (23c)
5M ago
PASG
PASG Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsPASG Upcoming Earnings Report: What to Expect?
5M ago
PASG
Passage Bio Presents Promising Data on PBFT02 Therapy
Premium
Company Announcements
Passage Bio Presents Promising Data on PBFT02 Therapy
6M ago
8K
PASG
Passage Bio delivered preclinical, interim data at ESGCT
Premium
The Fly
Passage Bio delivered preclinical, interim data at ESGCT
6M ago
PASG
Passage Bio Reveals Promising Gene Therapy Trial Results
PremiumCompany Announcements
Passage Bio Reveals Promising Gene Therapy Trial Results
7M ago
8K
PASG
Passage Bio to present data from Cohort 1 patients evaluating PBFT02
PremiumThe Fly
Passage Bio to present data from Cohort 1 patients evaluating PBFT02
7M ago
PASG
Passage Bio appoints Tom Kassberg to board of directors
PremiumThe Fly
Passage Bio appoints Tom Kassberg to board of directors
7M ago
PASG
RARE
Passage Bio Appoints Thomas Kassberg to Leadership Team
PremiumCompany Announcements
Passage Bio Appoints Thomas Kassberg to Leadership Team
7M ago
8K
PASG
Passage Bio initiated with a Buy at Rodman & Renshaw
PremiumThe FlyPassage Bio initiated with a Buy at Rodman & Renshaw
8M ago
PASG
Passage Bio Presents Updated Corporate Insights
Premium
Company Announcements
Passage Bio Presents Updated Corporate Insights
9M ago
8K
PASG
Passage Bio reports Q2 EPS (26c), consensus (31c)
Premium
The Fly
Passage Bio reports Q2 EPS (26c), consensus (31c)
9M ago
PASG

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >